RE:2nd phase III was already run for "SAFETY"....How many "patient experiences" were there in the failed ENDO phase III trial?
60, 80, 120, 140??
We were delivered two damaging NR's around this trial...how many patients added to our SAFETY PROFILE??
It looks like a lot of money was spent and it would seem that the FDA had their eye on the safety experience the whole time...the trial was stopped because of enrolment NOT because of sfety or efficacy.
I would like to see one of our "lead bullboard people" update this point with blogger Ford at Seeking Alpha..he missed this trial completely.